Musculoskeletal Pharmacology Part I Flashcards
1
Q
Skeletal Muscle Relaxants
A
- treat conditions with hyperexcitable skeletal muscle (i.e. spasticity and muscle spasms)
- goal is to normalize muscle excitability without profound decrease in muscle function
1
Q
UMN Lesions
A
- Site: Cerebral hemispheres, cerebellum, brainstem, spinal cord
- Muscle weakness: quadriplegia, hemiplegia, diplegia, paraplegia
- Muscle tone: spasticity, rigidity
- Sensory loss: cortical sensations
2
Q
LMN Lesions
A
- Site: AHC, Nerve roots, peripheral nerves, NMJ, muscles
- Muscle weakness: proximal (myopathy), distal (neuropathy)
- Muscle tone: hypotonia
- Sensory loss: peripheral sensations
3
Q
Spasticity
A
- velocity dependent increase in muscle tone caused by increased excitability of muscle stretch reflex
- central disorder (UMN)
- symptoms include stiffness, hypertonicity, hyperreflexia
4
Q
Spasms
A
- involuntary, sudden muscle contractions
- peripheral disorders (LMN), muscle sprain or injury, nerve compression, inflammation, electrolyte imbalances
- symptoms include jerks, twitches, cramps
5
Q
Spasticity common neurologic disorders
A
- multiple sclerosis
- stroke
- CP
- SCI, brain injuries
- Neurodegernative disorders affected UMN, pyramidal and extrapyramidal pathways
6
Q
Common symptoms of severe spasticity
A
- muscle stiffness (flexing or extending)- adducted shoulder with IR, flexed elbow, pronated forearm, flexed wrist and fingers, thumb in palm, clenched fist
- muscle spasms
- Clonus- rapid muscle contractions
- Contractures- fixed joints
- Exxagerated muscle jerks
- pain or tightness around joints
7
Q
Primary goal of skeletal muscle relaxants
A
- selective decrease in skeletal muscle excitability
- decrease pain
- without causing profound decrease in muscle function
- either antispasticity or antispasmodic (spasmolytic) agents
8
Q
Baclofen
A
- common antispasticity drug
- Acts on GABA-B receptors in spinal cord to inhibit reflexes and decrease spasticity
- can be taken orally or adminstered into spinal fluid
9
Q
Dantrolene
A
- common anti-spasticity drug
- acts directly on skeletal muscle, inhibits calcium release and thus muscle contraction
10
Q
Tizanidine
A
- common anti-spasticity drug
- Alpha-2 adrenergic agonist that reduced spasticity by increase presynaptic inhibition
11
Q
Botulinum toxin
A
- common anti spasticity drug
- injected directly into spastic muscles, inhibits ACh release, reducing muscle contractoin
12
Q
Carisoprodol (Soma)
A
- common spasmolytic
- exact mechanism unknown, alters interneuronal activity in spinal cord and descending reticular formation in brain
13
Q
Cyclobenzaprine (Flexeril)
A
- common spasmolytic
- works centrally, decreases activity in brainstem to relieve muscle spasms
14
Q
Methocarbamol (Robaxin)
A
- common spasmolytic
- mechanism not fully understoof, central muscle relaxant properties